Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1991 1
1994 3
1995 2
1996 3
1997 3
1998 3
1999 4
2000 2
2001 1
2002 4
2003 10
2004 11
2005 5
2006 12
2007 9
2008 11
2009 6
2010 8
2011 5
2012 5
2013 1
2014 2
2015 8
2016 6
2017 7
2018 4
2019 4
2020 7
2021 7
2022 8
2023 9
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

164 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial.
Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T, Todaka A, Yanagimoto H, Morinaga S, Kobayashi S, Shimada K, Takahashi Y, Nakagohri T, Gotoh K, Kamata K, Shimizu Y, Ueno M, Ishii H, Okusaka T, Furuse J; Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Nakachi K, et al. Among authors: nakagohri t. Lancet. 2023 Jan 21;401(10372):195-203. doi: 10.1016/S0140-6736(22)02038-4. Lancet. 2023. PMID: 36681415 Clinical Trial.
Clinical Practice Guidelines for Pancreatic Cancer 2022 from the Japan Pancreas Society: a synopsis.
Okusaka T, Nakamura M, Yoshida M, Kitano M, Ito Y, Mizuno N, Hanada K, Ozaka M, Morizane C, Takeyama Y; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society. Okusaka T, et al. Int J Clin Oncol. 2023 Apr;28(4):493-511. doi: 10.1007/s10147-023-02317-x. Epub 2023 Mar 15. Int J Clin Oncol. 2023. PMID: 36920680 Free PMC article.
Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial.
Morizane C, Okusaka T, Mizusawa J, Katayama H, Ueno M, Ikeda M, Ozaka M, Okano N, Sugimori K, Fukutomi A, Hara H, Mizuno N, Yanagimoto H, Wada K, Tobimatsu K, Yane K, Nakamori S, Yamaguchi H, Asagi A, Yukisawa S, Kojima Y, Kawabe K, Kawamoto Y, Sugimoto R, Iwai T, Nakamura K, Miyakawa H, Yamashita T, Hosokawa A, Ioka T, Kato N, Shioji K, Shimizu K, Nakagohri T, Kamata K, Ishii H, Furuse J; members of the Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group (JCOG-HBPOG). Morizane C, et al. Among authors: nakagohri t. Ann Oncol. 2019 Dec 1;30(12):1950-1958. doi: 10.1093/annonc/mdz402. Ann Oncol. 2019. PMID: 31566666 Free article. Clinical Trial.
[Gastric cancer].
Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Gotouda N. Kinoshita T, et al. Among authors: nakagohri t. Gan To Kagaku Ryoho. 2006 Mar;33(3):313-7. Gan To Kagaku Ryoho. 2006. PMID: 16531710 Review. Japanese.
Prognostic Impact of Margin Status in Distal Cholangiocarcinoma.
Nakagohri T, Takahashi S, Ei S, Masuoka Y, Mashiko T, Ogasawara T, Hirabayashi K. Nakagohri T, et al. World J Surg. 2023 Apr;47(4):1034-1041. doi: 10.1007/s00268-023-06889-7. Epub 2023 Feb 3. World J Surg. 2023. PMID: 36735046
Undifferentiated carcinoma of the ampulla of Vater.
Yamada M, Furukawa D, Yazawa N, Izumi H, Masuoka Y, Mashiko T, Kawaguchi Y, Ogawa M, Kawashima Y, Mine T, Hirabayashi K, Nakagohri T. Yamada M, et al. Among authors: nakagohri t. Surg Case Rep. 2017 Dec;3(1):9. doi: 10.1186/s40792-016-0284-9. Epub 2017 Jan 6. Surg Case Rep. 2017. PMID: 28063144 Free PMC article.
164 results